Jinee Rizzo

2.2k total citations · 1 hit paper
26 papers, 1.8k citations indexed

About

Jinee Rizzo is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Jinee Rizzo has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Jinee Rizzo's work include Cancer Treatment and Pharmacology (9 papers), Cancer therapeutics and mechanisms (8 papers) and Neutropenia and Cancer Infections (4 papers). Jinee Rizzo is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Cancer therapeutics and mechanisms (8 papers) and Neutropenia and Cancer Infections (4 papers). Jinee Rizzo collaborates with scholars based in United States, Netherlands and Germany. Jinee Rizzo's co-authors include Eric K. Rowinsky, Daniel D. Von Hoff, Lisa A. Hammond, Anthony W. Tolcher, Manuel Hidalgo, Chris H. Takimoto, Lillian L. Siu, Louis Denis, Sabine Eckhardt and Karen J. Ferrante and has published in prestigious journals such as Journal of Clinical Oncology, Applied and Environmental Microbiology and Clinical Cancer Research.

In The Last Decade

Jinee Rizzo

26 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

2001 830 citations Manuel Hidalgo, Lillian L. Siu et al. Journal of Clinical Oncology profile →

Peers

Jinee Rizzo

ONCOL

PRM

GENET

Robert J. Belt United States

M.E.L. van der Burg Netherlands

Heike Richly Germany

Andrew Goetz United States

Lila Adnane United States

Garry Schwartz United States

U. Vanhoefer Germany

G. Veerman Netherlands

Gerald J. Fetterly United States

Jackie Walling United States

Robert J. Belt United States

Jinee Rizzo

1.5k ×1.3

ONCOL

789 ×1.2

459 ×0.7

PRM

190 ×1.0

GENET

386 ×2.2

Citations per year, relative to Jinee Rizzo Jinee Rizzo (= 1×) peers Robert J. Belt

Countries citing papers authored by Jinee Rizzo

Since Specialization

Citations

This map shows the geographic impact of Jinee Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinee Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinee Rizzo more than expected).

Fields of papers citing papers by Jinee Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinee Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinee Rizzo. The network helps show where Jinee Rizzo may publish in the future.

Co-authorship network of co-authors of Jinee Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Jinee Rizzo. A scholar is included among the top collaborators of Jinee Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinee Rizzo. Jinee Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Posey, James, Muhammad Wasif Saif, Andrew Goetz, et al.. (2005). Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas. Clinical Cancer Research. 11(21). 7866–7871. 40 indexed citations

Schwartz, Garry, Amita Patnaik, L. A. Hammond, et al.. (2003). A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies. Annals of Oncology. 14(5). 775–782. 36 indexed citations

Malik, Shazli N., Lillian L. Siu, Eric K. Rowinsky, et al.. (2003). Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.. PubMed. 9(7). 2478–86. 104 indexed citations

Hao, Desirée, Jinee Rizzo, Daniel L. Dexter, et al.. (2002). Preclinical Antitumor Activity and Pharmacokinetics of Methyl-2-Benzimidazolecarbamate (FB642). Investigational New Drugs. 20(3). 261–270. 34 indexed citations

Rosing, Hilde, et al.. (2002). Determination of 9-nitrocamptothecin and its metabolite 9-aminocamptothecin in human plasma using high-performance liquid chromatography with ultraviolet and fluorescence detection. Journal of Chromatography B. 775(2). 231–237. 8 indexed citations

Tolcher, Anthony W., Jinee Rizzo, Elżbieta Izbicka, et al.. (2000). A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors. Annals of Oncology. 11(3). 333–338. 13 indexed citations

Rowinsky, Eric K., Thomas R. Johnson, Charles E. Geyer, et al.. (2000). DX-8951f, a Hexacyclic Camptothecin Analog, on a Daily-Times-Five Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies. Journal of Clinical Oncology. 18(17). 3151–3163. 37 indexed citations

Eckhardt, S. Gail, Jinee Rizzo, Kevin Sweeney, et al.. (1999). Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 17(4). 1095–1095. 55 indexed citations

Schreeder, Marshall T., et al.. (1999). Hepatic Artery Administration of Paclitaxel. Cancer Investigation. 17(2). 118–120. 7 indexed citations

10.

Schreeder, Marshall T., et al.. (1999). Hepatic Artery Administration of Paclitaxel. Cancer Investigation. 17(2). 118–120. 3 indexed citations

11.

Chang, Susan M., John G. Kuhn, Jinee Rizzo, et al.. (1998). Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.. Journal of Clinical Oncology. 16(6). 2188–2194. 131 indexed citations

12.

Hardin, T C, Laura K. Najvar, Jinee Rizzo, et al.. (1997). Discrepancy between in vitro and in vivo antifungal activity of albendazole.. PubMed. 35(3). 153–8. 7 indexed citations

13.

Kolesar, Jill, Jinee Rizzo, & John G. Kuhn. (1997). Quantitative analysis of NQO1 gene expression by RT-PCR and CE-LIF.. PubMed. 2(6). 287–90. 7 indexed citations

14.

Rizzo, Jinee, Alexandra M. Levine, Geoffrey R. Weiss, et al.. (1996). Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma. Investigational New Drugs. 14(2). 227–234. 12 indexed citations

15.

Weiss, Geoffrey R., John G. Kuhn, Jinee Rizzo, et al.. (1995). A Phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 35(5). 397–402. 12 indexed citations

16.

Brown, T.D., Kathleen A. Havlin, Geoffrey R. Weiss, et al.. (1991). A phase I trial of taxol given by a 6-hour intravenous infusion.. Journal of Clinical Oncology. 9(7). 1261–1267. 150 indexed citations

17.

Rizzo, Jinee, Christopher M. Riley, Daniel D. Von Hoff, et al.. (1990). Analysis of anticancer drugs in biological fluids: determination of taxol with application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis. 8(2). 159–164. 59 indexed citations

18.

Rizzo, Jinee & Patrick J. Davis. (1989). Microbial Models of Mammalian Metabolism: Conversion of Warfarin to 4′-Hydroxywarfarin Using Cunninghamella Bainieri. Journal of Pharmaceutical Sciences. 78(3). 183–189. 21 indexed citations

19.

Rizzo, Jinee & Patrick J. Davis. (1988). Microbial Models of Mammalian Metabolism: Production of Novel α-diketone Metabolites of Warfarin and Phenprocoumon UsingAspergillus Niger. Xenobiotica. 18(12). 1425–1437. 10 indexed citations

20.

Davis, Patrick J. & Jinee Rizzo. (1982). Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species. Applied and Environmental Microbiology. 43(4). 884–890. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact